Evidence map›Paper›PMID 33299969›Full record

ArticleiScience2020

Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease.

Yogesh Bhattarai, Si Jie, David R Linden, Sayak Ghatak, Ruben A T Mars, Brianna B Williams, Meng Pu, Justin L Sonnenburg, Michael A Fischbach, Gianrico Farrugia and 2 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Tracing NADCell reports · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Tracing NADResearch square · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Medicinal Cannabis and the Intestinal Microbiome.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Yogesh BhattaraiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Si JieDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
David R LindenDepartment of Physiology and Biomedical Engineering, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Sayak GhatakDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Ruben A T MarsDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Brianna B WilliamsDepartment of Bioengineering and ChEM-H, Stanford University, CA 94305, USA.
Meng PuDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Justin L SonnenburgDepartment of Microbiology and Immunology, Stanford University, Stanford, CA 94304, USA.
Michael A FischbachDepartment of Bioengineering and ChEM-H, Stanford University, CA 94305, USA.
Gianrico FarrugiaDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Lei ShaDepartment of Pharmacy, Department of Neuroendocrine Pharmacology, School of Pharmacy, China Medical University, 77 Pu He Road, Shenbei New District, Shenyang 110122, P.R. China.
Purna C KashyapDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Mayo Clinic in Arizona · USMayo Clinic · USStanford University · USChina Medical University · CN

Funding

Impact of Diet on Intestinal Microbiota-Host DynamicsR01DK085025 · NIDDK · STANFORD UNIVERSITY · PI JUSTIN L SONNENBURG · 2010 to 2026
$6.4M
Mechanisms of alteration of GI physiology by gut microbesR01DK114007 · NIDDK · MAYO CLINIC ROCHESTER · PI Purna C Kashyap · 2017 to 2026
$4.7M
NIDDK NIH HHS R01 DK085025NIDDK NIH HHS R01 DK114007
6 · The paper itself

Abstract

Recent studies emphasize the role of microbial metabolites in regulating gastrointestinal (GI) physiology through activation of host receptors, highlighting the potential for inter-kingdom signaling in treating GI disorders. In this study, we show that tryptamine, a tryptophan-derived bacterial metabolite, stimulates mucus release from goblet cells via activation of G-protein-coupled receptor (GPCR) 5-HT4R. Germ-free mice colonized with engineered

Indexed as

MicrobiologyRodent Gastroenterology

Identifiers

PMID33299969
PMCPMC7702010
OpenAlexW3098074732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.